Related Experiment Video
Updated: Jan 9, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Trajectory analysis of BMI increase induced by second-generation antipsychotics in first-episode schizophrenia: a
Xiaolin Yin1,2,3,4, Tianhang Zhou1,2,3,4, Bingjie Huang1,2,3,4
1Peking University Sixth Hospital, Beijing, China.
Abstract:
Antipsychotic-induced weight gain (AIWG) exhibits marked heterogeneity. We conducted a secondary analysis of the Chinese First-Episode Schizophrenia Trial, leveraging frequent body mass index (BMI) measurements over 12 months. Our aims were to identify latent BMI trajectories in first-episode schizophrenia (FES) patients treated with second-generation antipsychotics (SGAs) and to explore predictors of trajectory membership. Subjects in this study were from the Chinese First-Episode Schizophrenia Trial (CNFEST). After quality control, a total of 361 drug-naïve FES patients treated with olanzapine, risperidone, or aripiprazole were included. BMI was measured at 7 timepoints over 12 months. Latent class trajectory modeling (LCTM) was used to identify distinct BMI trajectories. Multinomial logistic regression was applied to detect predictors of trajectory membership. Four BMI trajectories were emerged, including Low Baseline BMI with Rapid Increase (LBRI) (6.1%, +3.5kg/m² within the first 3 months), Moderate Baseline BMI with Gradual Increase (MBGI) (33.8%, steady rising during 9 months), and Low/High Baseline BMI with Slight Increase (LBSI/HBSI) (46%/14.1%, Minimal change (<1.5 kg/m²)). Baseline BMI (χ² = 144.5, p < 0.001) was the strongest predictor of the LBRI trajectory. A numerically higher, though not statistically stable, odds were observed for olanzapine vs. aripiprazole (OR = 20.4, 95% CI = 2.48-166.67). Shorter duration of untreated psychosis (DUP < 1 year) (OR = 4.12, 95% CI = 1.31-12.93) and lower education (OR = 5.40, 95% CI = 1.19-24.52) further increased LBRI risk. A high-risk subgroup (LBRI) with rapid early weight gain was identified, driven by olanzapine use, shorter DUP, and lower educational attainment. These findings advocate for dynamic risk stratification and early preventive interventions in vulnerable FES patients (Trial Registration: This trial was registered at ClinicalTrials.gov (Identifier: NCT01057849) on January 26, 2010).
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
13:08Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
Related Concept Videos
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychological and Sociocultural Causes of Schizophrenia
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Mania and Antimanic Drugs: Overview